Marijuana Consumption: Health Impacts and Policy Challenges
Episode Overview
Dr. Myran explores Canada's leading role in marijuana consumption. He examines the effects of decriminalisation versus legalisation. Cannabis use is linked to increased anxiety and schizophrenia. His research faces criticism from both political spectrums. The importance of delaying substance use until brain maturity.
There's no quick fix to the opioid epidemic; it's a wicked policy problem needing diverse measures.
How can compelling narratives motivate and inspire others? This episode of High Truths on Drugs and Addiction features Dr. Daniel Myran, a public health researcher from Canada, who dives into the nitty-gritty of marijuana consumption and its impact on public health. As Canada tops the charts in marijuana use, Dr. Myran's research provides a fascinating look at how drug policies influence healthcare visits related to mental health and substance use.
He shares his insights on decriminalisation versus legalisation, highlighting the effects on police encounters and health outcomes. Dr. Myran's work doesn't shy away from controversy, as he navigates the political landscape that often challenges his findings. He discusses the potential health risks associated with cannabis use, including increased anxiety disorders, dementia diagnoses, and even schizophrenia. With a sprinkle of humour, Dr. Myran reflects on the joys of fatherhood amidst his prolific research career.
Listeners are treated to a thought-provoking discussion about the implications of drug policies and their societal impacts. The episode is a goldmine for anyone interested in understanding the complexities of substance use and its regulation. So, what do you think? Is legalisation the right path forward, or does it bring more harm than good?